27.04.2011 • News

Sun Pharma To Sell Some Merck Diabetes Drugs In India

Sun Pharmaceutical Industries has entered into a deal to market Merck & Co's diabetes drugs - sitagliptin and sitagliptin plus metformin  - in India, the two drugmakers said in a statement on Monday. Under the deal, Sun will have the rights to market the drugs only in India under different brand names, the firms said. Earlier in April, Sun and Merck formed a joint venture to develop and manufacture generic drugs for emerging markets.

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

Interview

Driving Transformation
Interconnected Global Chemicals Logistics

Driving Transformation

DP World is reshaping global chemical supply chains. Christene Smith of CHEManager interviews Markus Kanis, Global SVP Chemicals, on the company’s roadmap, new technologies, and the evolving demands of global trade.

Top-Feature

most read